MARAbio Systems, a tech-enabled precision immunology company, has received $19 million in Series A financing led by MAK Capital One.
MAK Capital's Michael A. Kaufman and Craig Nemiroff will join MARAbio's board of directors.
The company has developed a proprietary blood test to detect, treat and prevent Maternal Autoantibody Related Autism (MARA), a biological subtype of autism identifiable by a...
